Upstate Expands Offering Of Kinase Assay Kits For Drug Discovery 
10/19/2005 5:12:48 PM

ATLANTA--(BUSINESS WIRE)--Sept. 26, 2005--Serologicals Corporation (NASDAQ: SERO) today announced that Upstate Group, its wholly owned subsidiary, has expanded its KinEASE(TM) FP product line to include each of the 80 individual kinases that have been validated in the assay. By offering either a fluorescein green tracer or 645 nm FarRed tracer for reduced compound interference, there are a total of 160 new additions to its KinEASE(TM) FP activity assays.